Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
Twitter
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: cardiovascular risk
Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors
26th June 2017
Novartis has announced topline results from the global Phase III CANTOS study investigating the effi...